Literature DB >> 34081685

Patterns in COVID-19 Vaccination Coverage, by Social Vulnerability and Urbanicity - United States, December 14, 2020-May 1, 2021.

Vaughn Barry, Sharoda Dasgupta, Daniel L Weller, Jennifer L Kriss, Betsy L Cadwell, Charles Rose, Cassandra Pingali, Trieste Musial, J Danielle Sharpe, Stephen A Flores, Kurt J Greenlund, Anita Patel, Andrea Stewart, Judith R Qualters, LaTreace Harris, Kamil E Barbour, Carla L Black.   

Abstract

Disparities in vaccination coverage by social vulnerability, defined as social and structural factors associated with adverse health outcomes, were noted during the first 2.5 months of the U.S. COVID-19 vaccination campaign, which began during mid-December 2020 (1). As vaccine eligibility and availability continue to expand, assuring equitable coverage for disproportionately affected communities remains a priority. CDC examined COVID-19 vaccine administration and 2018 CDC social vulnerability index (SVI) data to ascertain whether inequities in COVID-19 vaccination coverage with respect to county-level SVI have persisted, overall and by urbanicity. Vaccination coverage was defined as the number of persons aged ≥18 years (adults) who had received ≥1 dose of any Food and Drug Administration (FDA)-authorized COVID-19 vaccine divided by the total adult population in a specified SVI category.† SVI was examined overall and by its four themes (socioeconomic status, household composition and disability, racial/ethnic minority status and language, and housing type and transportation). Counties were categorized into SVI quartiles, in which quartile 1 (Q1) represented the lowest level of vulnerability and quartile 4 (Q4), the highest. Trends in vaccination coverage were assessed by SVI quartile and urbanicity, which was categorized as large central metropolitan, large fringe metropolitan (areas surrounding large cities, e.g., suburban), medium and small metropolitan, and nonmetropolitan counties.§ During December 14, 2020-May 1, 2021, disparities in vaccination coverage by SVI increased, especially in large fringe metropolitan (e.g., suburban) and nonmetropolitan counties. By May 1, 2021, vaccination coverage was lower among adults living in counties with the highest overall SVI; differences were most pronounced in large fringe metropolitan (Q4 coverage = 45.0% versus Q1 coverage = 61.7%) and nonmetropolitan (Q4 = 40.6% versus Q1 = 52.9%) counties. Vaccination coverage disparities were largest for two SVI themes: socioeconomic status (Q4 = 44.3% versus Q1 = 61.0%) and household composition and disability (Q4 = 42.0% versus Q1 = 60.1%). Outreach efforts, including expanding public health messaging tailored to local populations and increasing vaccination access, could help increase vaccination coverage in high-SVI counties.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34081685     DOI: 10.15585/mmwr.mm7022e1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  35 in total

1.  A Community-Informed Approach to COVID-19 Vaccine Roll-Out in Under-served Areas in Chicago.

Authors:  Laura DiVirgilio; Arianna Boshara; Bijou R Hunt; Jacquelyn Jacobs; Kate Just; Amy K Johnson
Journal:  Front Public Health       Date:  2022-06-20

2.  Spatial Patterns of COVID-19 Vaccination Coverage by Social Vulnerability Index and Designated COVID-19 Vaccine Sites in Texas.

Authors:  Dania Mofleh; Maha Almohamad; Ikponmwosa Osaghae; Sandra Bempah; Qianzi Zhang; Guillermo Tortolero; Ahmad Ebeidat; Ryan Ramphul; Shreela V Sharma
Journal:  Vaccines (Basel)       Date:  2022-04-08

3.  Health and education concerns about returning to campus and online learning during the COVID-19 pandemic among US undergraduate STEM majors.

Authors:  Lindsay E Palmer; Sherry L Pagoto; Deja Workman; Kathrine A Lewis; Lauren Rudin; Nina De Luna; Valeria Herrera; Nathanial Brown; Jessica Bibeau; Kaylei Arcangel; Molly E Waring
Journal:  J Am Coll Health       Date:  2021-10-19

4.  Heterogeneity in Spatial Inequities in COVID-19 Vaccination Across 16 Large US Cities.

Authors:  Usama Bilal; Pricila H Mullachery; Alina Schnake-Mahl; Heather Rollins; Edwin McCulley; Jennifer Kolker; Sharrelle Barber; Ana V Diez Roux
Journal:  Am J Epidemiol       Date:  2022-08-22       Impact factor: 5.363

5.  Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.

Authors:  Jefferson M Jones; Mars Stone; Hasan Sulaeman; Rebecca V Fink; Honey Dave; Matthew E Levy; Clara Di Germanio; Valerie Green; Edward Notari; Paula Saa; Brad J Biggerstaff; Donna Strauss; Debra Kessler; Ralph Vassallo; Rita Reik; Susan Rossmann; Mark Destree; Kim-Anh Nguyen; Merlyn Sayers; Chris Lough; Daniel W Bougie; Megan Ritter; Gerardo Latoni; Billy Weales; Stacy Sime; Jed Gorlin; Nicole E Brown; Carolyn V Gould; Kevin Berney; Tina J Benoit; Maureen J Miller; Dane Freeman; Deeksha Kartik; Alicia M Fry; Eduardo Azziz-Baumgartner; Aron J Hall; Adam MacNeil; Adi V Gundlapalli; Sridhar V Basavaraju; Susan I Gerber; Monica E Patton; Brian Custer; Phillip Williamson; Graham Simmons; Natalie J Thornburg; Steven Kleinman; Susan L Stramer; Jean Opsomer; Michael P Busch
Journal:  JAMA       Date:  2021-10-12       Impact factor: 56.272

Review 6.  The benefits, costs and feasibility of a low incidence COVID-19 strategy.

Authors:  Thomas Czypionka; Emil N Iftekhar; Barbara Prainsack; Viola Priesemann; Simon Bauer; André Calero Valdez; Sarah Cuschieri; Enrico Glaab; Eva Grill; Jenny Krutzinna; Christos Lionis; Helena Machado; Carlos Martins; George N Pavlakis; Matjaž Perc; Elena Petelos; Martyn Pickersgill; Alexander Skupin; Eva Schernhammer; Ewa Szczurek; Sotirios Tsiodras; Peter Willeit; Paul Wilmes
Journal:  Lancet Reg Health Eur       Date:  2022-01-02

7.  COVID-19 Vaccination Uptake and Hesitancy Among Current Tobacco Users.

Authors:  Nicolle M Krebs; Gail D'Souza; Candace Bordner; Sophia I Allen; Andrea L Hobkirk; Jonathan Foulds; Jessica M Yingst
Journal:  Tob Use Insights       Date:  2021-12-20

8.  Participatory Approaches to Addressing Missing COVID-19 Race and Ethnicity Data.

Authors:  Farah Kader; Clyde Lanford Smith
Journal:  Int J Environ Res Public Health       Date:  2021-06-18       Impact factor: 3.390

9.  Socioeconomic variation in characteristics, outcomes, and healthcare utilization of COVID-19 patients in New York City.

Authors:  Yongkang Zhang; Dhruv Khullar; Fei Wang; Peter Steel; Yiyuan Wu; Duncan Orlander; Mark Weiner; Rainu Kaushal
Journal:  PLoS One       Date:  2021-07-29       Impact factor: 3.240

10.  COVID-19 Vaccination Coverage Among Adults - United States, December 14, 2020-May 22, 2021.

Authors:  Jill Diesel; Natalie Sterrett; Sharoda Dasgupta; Jennifer L Kriss; Vaughn Barry; Kayla Vanden Esschert; Ari Whiteman; Betsy L Cadwell; Daniel Weller; Judith R Qualters; LaTreace Harris; Achal Bhatt; Charnetta Williams; LeAnne M Fox; Dana Meaney Delman; Carla L Black; Kamil E Barbour
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-06-25       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.